Cargando…
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
BACKGROUND: Diabetes is an independent predictor of poor outcomes in patients with COVID-19. We compared the effects of the preadmission use of antidiabetic medications on the in-hospital mortality of patients with COVID-19 having type 2 diabetes. METHODS: A systematic search of PubMed, EMBASE, Scop...
Autores principales: | Nguyen, Nam Nhat, Ho, Dung Si, Nguyen, Hung Song, Ho, Dang Khanh Ngan, Li, Hung-Yuan, Lin, Chia-Yuan, Chiu, Hsiao-Yean, Chen, Yang-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970613/ https://www.ncbi.nlm.nih.gov/pubmed/35367460 http://dx.doi.org/10.1016/j.metabol.2022.155196 |
Ejemplares similares
-
ODP632 Preadmission Use Of Antidiabetic Medications And Mortality Among Patients With Covid-19 Having Type 2 Diabetes: A Meta-analysis
por: Nguyen, Nam Nhat, et al.
Publicado: (2022) -
Effect of preadmission beta‐blockade on mortality in multiple trauma
por: Eriksson, M., et al.
Publicado: (2018) -
Significance of preadmission quality of life for mortality in the ICU: a prospective cohort study
por: Bukan, RB, et al.
Publicado: (2013) -
COVID-19 and Virtual Nutrition: A Pilot Study of Integrating Digital Food Models for Interactive Portion Size Education
por: Ho, Dang Khanh Ngan, et al.
Publicado: (2022) -
Association of Preadmission Statin Use and Mortality in Critically Ill Patients: A Meta-Analysis of Cohort Studies
por: Yu, Shao-shuo, et al.
Publicado: (2021)